6201 - 6250 of 9145 Results
Title
Year
-
OPENTitle: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and humanJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 11Start Page: 1861End Page: 1883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20180248Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/11/1861/691623/bcj-2018-0248.pdfCitation Count: 219
-
OPENTitle: Phenotypic characterization of recessive gene knockout rat models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 70Issue #:Start Page: 190End Page: 203Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1016/j.nbd.2014.06.009Best OA location URL: https://doi.org/10.1016/j.nbd.2014.06.009Citation Count: 227
-
OPENTitle: Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral OrgansJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 11Start Page: e80705End Page: e80705Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0080705Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0080705&type=printableCitation Count: 187
-
OPENTitle: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 771End Page: 782Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27361Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27361Citation Count: 205
-
OPENTitle: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitorsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 473Issue #: 17Start Page: 2671End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160557Best OA location URL: https://portlandpress.com/biochemj/article-pdf/473/17/2671/687564/bj4732671.pdfCitation Count: 182
-
OPENTitle: Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophilsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 23End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170803Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/23/694098/bcj-2017-0803.pdfCitation Count: 179
- Crossroads in GDNF therapy for Parkinson's disease2006RESTRICTEDTitle: Crossroads in GDNF therapy for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 2Start Page: 136End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20861Citation Count: 174
-
OPENTitle: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 1End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170802Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/1/694077/bcj-2017-0802.pdfCitation Count: 166
-
OPENTitle: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 89Issue #: 19Start Page: 1959End Page: 1969Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000004609Best OA location URL: https://n.neurology.org/content/neurology/89/19/1959.full.pdfCitation Count: 152
-
OPENTitle: Six Action Steps to Address Global Disparities in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 9Start Page: 929End Page: 929Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2793874/jamaneurology_schiess_2022_sc_220001_1662471546.98796.pdfCitation Count: 144
-
OPENTitle: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 3Start Page: 312End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2773698/jamaneurology_simuni_2020_oi_200091_1614894403.37383.pdfCitation Count: 146
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 116
-
OPENTitle: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary resultsJournal Name: Journal of Translational MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 348End Page: 348Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12967-015-0704-9Best OA location URL: https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-015-0704-9Citation Count: 105
-
OPENTitle: The Parkinson's Disease Genome‐Wide Association Study Locus BrowserJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2056End Page: 2067Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28197Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-00254%22Citation Count: 104
- Which dyskinesia scale best detects treatment response?2013RESTRICTEDTitle: Which dyskinesia scale best detects treatment response?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 341End Page: 346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25321Citation Count: 89
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 85
-
OPENTitle: Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic DevelopmentJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27818Best OA location URL: https://doi.org/10.1002/mds.27818Citation Count: 86
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1216End Page: 1228Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28472Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28472Citation Count: 76
- Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol2016OPENTitle: Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study ProtocolJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 5Issue #: 3Start Page: e172End Page: e172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/resprot.5990Best OA location URL: https://www.researchprotocols.org/2016/3/e172/PDFCitation Count: 73
-
OPENTitle: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communitiesJournal Name: Preventive MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6354577Citation Count: 60
-
OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://escholarship.org/uc/item/1rb4t3mzCitation Count: 61
-
OPENTitle: The Future of GDNF in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 593572End Page: 593572Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.593572Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/pdfCitation Count: 50
- Real-World Experience With VMAT2 Inhibitors2019RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 50
-
OPENTitle: Childhood Stiff-Person Syndrome Improved with RituximabJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 4Issue #: 2Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000339446Best OA location URL: https://www.karger.com/Article/Pdf/339446Citation Count: 47
-
OPENTitle: Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 3Issue #: 3Start Page: 116End Page: 132Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1159/000502951Best OA location URL: https://www.karger.com/Article/Pdf/502951Citation Count: 46
- Media hype: Patient and scientific perspectives on misleading medical news2017RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 44
- Biomarkers for Parkinson’s Disease2011RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page: 79ps14End Page: 79ps14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
OPENTitle: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortiumJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1740End Page: 1744Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25600Best OA location URL: http://hdl.handle.net/11573/1383084Citation Count: 41
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://mhealth.amegroups.com/article/viewFile/10369/pdfCitation Count: 35
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 40
-
OPENTitle: Impact of motor fluctuations on real-life gait in Parkinson’s patientsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 62Issue #:Start Page: 388End Page: 394Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045Best OA location URL: https://publications.aston.ac.uk/id/eprint/33121/1/1_s2.0_S0966636218302832_main.pdfCitation Count: 34
-
OPENTitle: Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 2Start Page: 308End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51236Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51236Citation Count: 33
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150570Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150570?id=journal-of-parkinsons-disease%2Fjpd150570Citation Count: 30
-
OPENTitle: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In PersonJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 677End Page: 691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191808Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191808?id=journal-of-parkinsons-disease%2Fjpd191808Citation Count: 28
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 29
-
OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 26
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 24
-
OPENTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 26
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 2381468320978407End Page: 2381468320978407Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 23
-
OPENTitle: Recruitment for Remote Decentralized Studies in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 371End Page: 380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212935Best OA location URL: https://escholarship.org/uc/item/0k98f47rCitation Count: 22
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page: E87End Page: E87Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 23
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 18
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 13
-
OPENTitle: Understanding the Lexicon of Fatigue in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1185End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202029Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202029?id=journal-of-parkinsons-disease%2Fjpd202029Citation Count: 15
-
OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458013003187Citation Count: 41
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
-
OPENTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 8
-
OPENTitle: Lack of association between G6PD variants and Parkinson diseaseJournal Name: Human Genetics and Genomics AdvancesPublisher: Elsevier BVVol: 7Issue #: 1Start Page: 100555End Page: 100555Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xhgg.2025.100555Best OA location URL: https://doi.org/10.1016/j.xhgg.2025.100555Citation Count: 0